[HTML][HTML] Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations

LC Tao, J Xu, T Wang, F Hua, JJ Li - Cardiovascular Diabetology, 2022 - Springer
The triglyceride-glucose (TyG) index has been identified as a reliable alternative biomarker
of insulin resistance (IR). Recently, a considerable number of studies have provided robust …

The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030

B Vogel, M Acevedo, Y Appelman, CNB Merz… - The Lancet, 2021 - thelancet.com
Cardiovascular disease is the leading cause of death in women. Decades of grassroots
campaigns have helped to raise awareness about the impact of cardiovascular disease in …

[HTML][HTML] Intravascular imaging–guided or angiography-guided complex PCI

JM Lee, KH Choi, YB Song, JY Lee… - … England Journal of …, 2023 - Mass Medical Soc
Background Data regarding clinical outcomes after intravascular imaging–guided
percutaneous coronary intervention (PCI) for complex coronary-artery lesions, as compared …

[HTML][HTML] Percutaneous revascularization for ischemic left ventricular dysfunction

D Perera, T Clayton, PD O'Kane… - … England Journal of …, 2022 - Mass Medical Soc
Background Whether revascularization by percutaneous coronary intervention (PCI) can
improve event-free survival and left ventricular function in patients with severe ischemic left …

[HTML][HTML] Timing of complete revascularization with multivessel PCI for myocardial infarction

BE Stähli, F Varbella, A Linke, B Schwarz… - … England Journal of …, 2023 - Mass Medical Soc
Background In patients with ST-segment elevation myocardial infarction (STEMI) with
multivessel coronary artery disease, the time at which complete revascularization of …

[HTML][HTML] Fractional flow reserve–guided PCI as compared with coronary bypass surgery

WF Fearon, FM Zimmermann… - … England Journal of …, 2022 - Mass Medical Soc
Background Patients with three-vessel coronary artery disease have been found to have
better outcomes with coronary-artery bypass grafting (CABG) than with percutaneous …

Comparison of clopidogrel monotherapy after 1 to 2 months of dual antiplatelet therapy with 12 months of dual antiplatelet therapy in patients with acute coronary …

H Watanabe, T Morimoto, M Natsuaki… - JAMA …, 2022 - jamanetwork.com
Importance Clopidogrel monotherapy after short dual antiplatelet therapy (DAPT) after
percutaneous coronary intervention (PCI) has not yet been fully investigated in patients with …

GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease

D Wang, EA Day, LK Townsend, D Djordjevic… - Nature Reviews …, 2021 - nature.com
Abstract Growth differentiation factor 15 (GDF15) is a member of the TGFβ superfamily
whose expression is increased in response to cellular stress and disease as well as by …

Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient data meta …

MS Sabatine, BA Bergmark, SA Murphy, PT O'Gara… - The Lancet, 2021 - thelancet.com
Background The optimal revascularisation strategy for patients with left main coronary artery
disease is uncertain. We therefore aimed to evaluate long-term outcomes for patients treated …

Effect of ticagrelor monotherapy vs ticagrelor with aspirin on major bleeding and cardiovascular events in patients with acute coronary syndrome: the TICO …

BK Kim, SJ Hong, YH Cho, KH Yun, YH Kim, Y Suh… - Jama, 2020 - jamanetwork.com
Importance Discontinuing aspirin after short-term dual antiplatelet therapy (DAPT) was
evaluated as a bleeding reduction strategy. However, the strategy of ticagrelor monotherapy …